Table 2.
Phenotypic features of our women cohort used in the study
| PCOS women (n = 118) |
Controls (n = 150) |
P (X 2)a | |
|---|---|---|---|
| Age (years) | 29.8 ± 0.4 | 33.5 ± 0.5 | <0.0001 |
| BMI (kg/m2) | 28.4 ± 0.7 | 23.1 ± 0.2 | <0.0001 |
| Random glycemia (mmol/L) | 7.9 ± 0.2 | 4.5 ± 0.1 | <0.0001 |
| Fasting insulin (mU/L) | 15.7 ± 1.2 | 7.7 ± 0.4 | 0.01 |
| Testosterone (nmol/L) | 2.9 ± 0.2 | 1.0 ± 0.1 | <0.0001 |
| Prolactin (mU/L) | 73.1 ± 11.7 | 148.8 ± 9.4 | 0.0001 |
| Triglycerides (mmol/L) | 1.7 ± 0.1 | 1.0 ± 0.1 | 0.0001 |
| LDL cholesterol | 3.1 ± 0.1 | 1.9 ± 0.2 | <0.0001 |
| MetS ATPIII (%) | 34.7 | 0.0 | <0.0001 |
aThe significance of the difference between cases and controls is assessed by X 2 test